tiprankstipranks
Pelthos Therapeutics (PTHS)
XASE:PTHS
US Market
Want to see PTHS full AI Analyst Report?

Pelthos Therapeutics (PTHS) Ownership - Who Owns Pelthos Therapeutics?

73 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 15, 2026
xxxxxxxxxxxxx
$999817
May 26, 2026
xxxxxxxxxxxxx
$40260
Nov 26, 2025
xxxxxxxxxxxxx
$280261
Jul 03, 2025
xxxxxxxxxxxxx
$800000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,575,834Insider45.34%40,609,242
1,500,000Insider43.16%38,655,000
203,672Insider5.86%5,248,627
94,136Institution2.71%2,425,885
91,004Institution2.62%2,345,173
40,841Insider1.18%1,052,473
28,462Insider0.82%733,466
24,681Insider0.71%636,029
15,150Insider0.44%390,416
12,000Insider0.35%309,240

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
91,004Institution2.62%2,345,173
10,835Institution0.31%279,218
2,089Institution0.06%53,834

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
78,008Institution2.24%2,064,872
16,128Institution0.46%426,908
4,991Institution0.14%128,618

FAQ

Who Owns Pelthos Therapeutics (PTHS)?
Currently, no data Available
What percentage of Pelthos Therapeutics (PTHS) stock is held by institutional investors?
Currently, no data Available
What percentage of Pelthos Therapeutics (PTHS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Pelthos Therapeutics (PTHS)?
Todd Davis owns the most shares of Pelthos Therapeutics (PTHS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.